Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Epeleuton by Afimmune Biopharma for Sickle Cell Disease: Likelihood of Approval
Epeleuton is under clinical development by Afimmune Biopharma and currently in Phase II for Sickle Cell Disease. According to GlobalData,...